Case number 1:23-cv-00039
Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 16, 2023 | 16 | NOTICE OF SERVICE of Merck KGaA, Merck Serono SA, and Ares Trading SA's Initial Infringement Contentions filed by Ares Trading SA, Merck KGaA, Merck Serono SA.(Tigan, Jeremy) (Entered: 06/16/2023) (3) |
| Jun 7, 2023 | N/A | SO ORDERED, re (18 in 1:22-cv-01365-GBW, 15 in 1:23-cv-00039-GBW) Agreement Regarding Discovery of Electronically Stored Information and [Proposed] Order. Signed by Judge Gregory B. Williams on 6/7/23. Associated Cases: 1:22-cv-01365-GBW, 1:23-cv-00039-GBW (ntl) (Entered: 06/07/2023) (0) |
| Jun 2, 2023 | 15 | Joint PROPOSED ORDER -- Agreement Regarding Discovery of Electronically Stored Information and [Proposed] Order -- by Ares Trading SA, Merck KGaA, Merck Serono SA. (Tigan, Jeremy) (Entered: 06/02/2023) (22) |
| May 19, 2023 | N/A | SO ORDERED, re 14 STIPULATION TO EXTEND TIME for the parties to file a Proposed Order Governing Electronic Discovery to June 2, 2023 filed by Ares Trading SA, Merck Serono SA, Merck KGaA. Signed by Judge Gregory B. Williams on 5/19/23. (ntl) (Entered: 05/19/2023) (0) |
| May 18, 2023 | 14 | STIPULATION TO EXTEND TIME for the parties to file a Proposed Order Governing Electronic Discovery to June 2, 2023 - filed by Ares Trading SA, Merck KGaA, Merck Serono SA. (Tigan, Jeremy) (Entered: 05/18/2023) (2) |
| May 5, 2023 | 13 | NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Paragraph 4(a) of the Default Standard for Discovery filed by Ares Trading SA, Merck KGaA, Merck Serono SA.(Tigan, Jeremy) (Entered: 05/05/2023) (3) |
| May 2, 2023 | 12 | Joint PROPOSED ORDER -- [Proposed] Scheduling Order -- by Ares Trading SA, Merck KGaA, Merck Serono SA. (Attachments: # 1 Cover Letter to The Honorable Gregory B. Williams)(Tigan, Jeremy) (Entered: 05/02/2023) (Cover Letter to The Honorable Gregory B. Williams) (1) |
| May 2, 2023 | 12 | Joint PROPOSED ORDER -- [Proposed] Scheduling Order -- by Ares Trading SA, Merck KGaA, Merck Serono SA. (Attachments: # 1 Cover Letter to The Honorable Gregory B. Williams)(Tigan, Jeremy) (Entered: 05/02/2023) (Main Document) (14) |
| Feb 3, 2023 | 10 | ANSWER to 1 Complaint, with Affirmative Defenses by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Schladweiler, Benjamin) (Entered: 02/03/2023) (Main Document) (21) |
| Feb 3, 2023 | 11 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Schladweiler, Benjamin) (Entered: 02/03/2023) (2) |
| Feb 3, 2023 | 10 | ANSWER to 1 Complaint, with Affirmative Defenses by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Schladweiler, Benjamin) (Entered: 02/03/2023) (Exhibit A) (6) |
| Feb 3, 2023 | 10 | ANSWER to 1 Complaint, with Affirmative Defenses by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Schladweiler, Benjamin) (Entered: 02/03/2023) (Exhibit B) (3) |
| Feb 3, 2023 | 10 | ANSWER to 1 Complaint, with Affirmative Defenses by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Schladweiler, Benjamin) (Entered: 02/03/2023) (Exhibit C) (12) |
| Feb 3, 2023 | 10 | ANSWER to 1 Complaint, with Affirmative Defenses by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Schladweiler, Benjamin) (Entered: 02/03/2023) (Exhibit D) (4) |
| Feb 3, 2023 | 10 | ANSWER to 1 Complaint, with Affirmative Defenses by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Schladweiler, Benjamin) (Entered: 02/03/2023) (Exhibit E) (21) |
| Feb 3, 2023 | 10 | ANSWER to 1 Complaint, with Affirmative Defenses by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Schladweiler, Benjamin) (Entered: 02/03/2023) (Exhibit F) (10) |
| Feb 3, 2023 | 10 | ANSWER to 1 Complaint, with Affirmative Defenses by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Schladweiler, Benjamin) (Entered: 02/03/2023) (Exhibit G) (4) |
| Feb 3, 2023 | 10 | ANSWER to 1 Complaint, with Affirmative Defenses by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Schladweiler, Benjamin) (Entered: 02/03/2023) (Exhibit H) (3) |
| Feb 2, 2023 | N/A | Pro Hac Vice Attorney Kenneth S. Canfield, Dmitry V. Shelhoff, Edward D. Pergament, and Julia S. Kim for Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/02/2023) (0) |
| Feb 1, 2023 | N/A | SO ORDERED, re 9 MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Kenneth S. Canfield, Edward D. Pergament and Julia S. Kim filed by Aurobindo Pharma USA, Inc., Aurobindo Pharma Limited. Signed by Judge Gregory B. Williams on 2/1/23. (ntl) (Entered: 02/01/2023) (0) |
| Jan 31, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Kenneth S. Canfield, Edward D. Pergament and Julia S. Kim - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Certification by Counsel to Be Admitted Pro Hac Vice - Dmitry V. Shelhoff, Esq., # 3 Certification by Counsel to Be Admitted Pro Hac Vice - Kenneth S. Canfield, Esq., # 4 Certification by Counsel to Be Admitted Pro Hac Vice - Edward D. Pergament, Esq., # 5 Certification by counsel to Be Admitted Pro Hac Vice - Julia S. Kim, Esq.)(Schladweiler, Benjamin) (Entered: 01/31/2023) (Certification by counsel to Be Admitted Pro Hac Vice - Julia S. Kim, Esq.) (1) |
| Jan 31, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Kenneth S. Canfield, Edward D. Pergament and Julia S. Kim - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Certification by Counsel to Be Admitted Pro Hac Vice - Dmitry V. Shelhoff, Esq., # 3 Certification by Counsel to Be Admitted Pro Hac Vice - Kenneth S. Canfield, Esq., # 4 Certification by Counsel to Be Admitted Pro Hac Vice - Edward D. Pergament, Esq., # 5 Certification by counsel to Be Admitted Pro Hac Vice - Julia S. Kim, Esq.)(Schladweiler, Benjamin) (Entered: 01/31/2023) (Certification by Counsel to Be Admitted Pro Hac Vice - Edward D. Pergament, Esq) (1) |
| Jan 31, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Kenneth S. Canfield, Edward D. Pergament and Julia S. Kim - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Certification by Counsel to Be Admitted Pro Hac Vice - Dmitry V. Shelhoff, Esq., # 3 Certification by Counsel to Be Admitted Pro Hac Vice - Kenneth S. Canfield, Esq., # 4 Certification by Counsel to Be Admitted Pro Hac Vice - Edward D. Pergament, Esq., # 5 Certification by counsel to Be Admitted Pro Hac Vice - Julia S. Kim, Esq.)(Schladweiler, Benjamin) (Entered: 01/31/2023) (Certification by Counsel to Be Admitted Pro Hac Vice - Kenneth S. Canfield, Esq) (1) |
| Jan 31, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Kenneth S. Canfield, Edward D. Pergament and Julia S. Kim - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Certification by Counsel to Be Admitted Pro Hac Vice - Dmitry V. Shelhoff, Esq., # 3 Certification by Counsel to Be Admitted Pro Hac Vice - Kenneth S. Canfield, Esq., # 4 Certification by Counsel to Be Admitted Pro Hac Vice - Edward D. Pergament, Esq., # 5 Certification by counsel to Be Admitted Pro Hac Vice - Julia S. Kim, Esq.)(Schladweiler, Benjamin) (Entered: 01/31/2023) (Certification by Counsel to Be Admitted Pro Hac Vice - Dmitry V. Shelhoff, Esq.) (1) |
| Jan 31, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Kenneth S. Canfield, Edward D. Pergament and Julia S. Kim - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Certification by Counsel to Be Admitted Pro Hac Vice - Dmitry V. Shelhoff, Esq., # 3 Certification by Counsel to Be Admitted Pro Hac Vice - Kenneth S. Canfield, Esq., # 4 Certification by Counsel to Be Admitted Pro Hac Vice - Edward D. Pergament, Esq., # 5 Certification by counsel to Be Admitted Pro Hac Vice - Julia S. Kim, Esq.)(Schladweiler, Benjamin) (Entered: 01/31/2023) (Main Document) (1) |
| Jan 31, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Kenneth S. Canfield, Edward D. Pergament and Julia S. Kim - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Certification by Counsel to Be Admitted Pro Hac Vice - Dmitry V. Shelhoff, Esq., # 3 Certification by Counsel to Be Admitted Pro Hac Vice - Kenneth S. Canfield, Esq., # 4 Certification by Counsel to Be Admitted Pro Hac Vice - Edward D. Pergament, Esq., # 5 Certification by counsel to Be Admitted Pro Hac Vice - Julia S. Kim, Esq.)(Schladweiler, Benjamin) (Entered: 01/31/2023) (Text of Proposed Order) (1) |
| Jan 20, 2023 | 7 | AFFIDAVIT of Service for Summons, Complaint and related papers served on Aurobindo Pharma Limited on January 19, 2023, filed by Ares Trading SA, Merck KGaA, Merck Serono SA. (Tigan, Jeremy) (Entered: 01/20/2023) (10) |
| Jan 20, 2023 | 8 | SUMMONS Returned Executed by Merck Serono SA, Merck KGaA, Ares Trading SA.Aurobindo Pharma USA, Inc. served on 1/20/2023, answer due 2/10/2023. (Tigan, Jeremy) (Entered: 01/20/2023) (2) |
| Jan 18, 2023 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 01/18/2023) (0) |
| Jan 13, 2023 | 1 | COMPLAINT filed against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. ( Filing fee $ 402, receipt number ADEDC-4043418.) - filed by Merck Serono SA, Merck KGaA, Ares Trading SA. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(apk) (Entered: 01/13/2023) (Exhibit A-D) (30) |
| Jan 13, 2023 | 1 | COMPLAINT filed against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. ( Filing fee $ 402, receipt number ADEDC-4043418.) - filed by Merck Serono SA, Merck KGaA, Ares Trading SA. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(apk) (Entered: 01/13/2023) (Civil Cover Sheet) (1) |
| Jan 13, 2023 | 1 | COMPLAINT filed against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. ( Filing fee $ 402, receipt number ADEDC-4043418.) - filed by Merck Serono SA, Merck KGaA, Ares Trading SA. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(apk) (Entered: 01/13/2023) (Main Document) (13) |
| Jan 13, 2023 | 6 | Summons Issued as to Aurobindo Pharma Limited on 1/13/2023; Aurobindo Pharma USA, Inc. on 1/13/2023. (Attachments: # 1 Summons Issued)(apk) (Attachment 1 replaced on 1/19/2023) (ntl). (Entered: 01/13/2023) (Main Document) (2) |
| Jan 13, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck KGaA for Ares Trading SA, Merck Serono SA filed by Ares Trading SA, Merck KGaA, Merck Serono SA. (apk) (Entered: 01/13/2023) (2) |
| Jan 13, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,713,947 B2 ;8,377,903 B2 ;10,849,919 B2. (apk) (Entered: 01/13/2023) (1) |
| Jan 13, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/5/2022. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 6/5/2025. (apk) (Entered: 01/13/2023) (1) |
| Jan 13, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 01/13/2023) (3) |
| Jan 13, 2023 | 6 | Summons Issued as to Aurobindo Pharma Limited on 1/13/2023; Aurobindo Pharma USA, Inc. on 1/13/2023. (Attachments: # 1 Summons Issued)(apk) (Attachment 1 replaced on 1/19/2023) (ntl). (Entered: 01/13/2023) (Summons Issued) (2) |
